Peptides Anti-Aging & Longevity
FOXO4-DRI
FOXO4-DRI · DRI-FOXO4
Modified peptide that nudges senescent cells toward apoptosis by interfering with the FOXO4–p53 interaction.
Pharmacokinetic summary
- Model tier
- Simple (t½ + F, Tmax estimated)
- Half-life
- 0.5 days
- Bioavailability
- 50%
- Typical dose
- 5–20 mg